Larvol Delta - Efficacy-of-Anifrolumab-Across-Multiple-Organ-Systems-in-Patients-with-Moderate-to-Severe-Systemic-Lupus-Erythematosus-A-PostHoc-Analysis-of-the-Phase-III-AZALEA-trial

Benlysta (belimumab) - GSK

Saphnelo (anifrolumab-fnia) - AstraZeneca

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1898062&mode=presInfo

Arjun Mahajan, MS

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next